According to a recent article from The Hill, federal appeals court has greenlit a lawsuit against the FDA over its stance on ivermectin as a COVID-19 treatment. Three doctors alleged that the FDA exceeded its authority by aggressively campaigning against the use of ivermectin for COVID-19, arguing that the agency acted more like a medical body than a regulator. The 5th Circuit Appeals Court ruled in favor of the doctors, stating that while the FDA can inform and apprise, it should not endorse, denounce, or advise on specific medical treatments. The FDA's campaign emphasized that ivermectin, an anti-parasitic medication used in both humans and animals, was not authorized for COVID-19 treatment.
Appeals Court Revives Lawsuit Against FDA Over Ivermectin Messaging
Federal appeals court breathes new life into lawsuit against FDA over COVID-19 ivermectin campaign.
Sep 7, 2023
EKATERINA BOLOVTSOVA
INTRODUCING! The Latest Trends for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
Read More